Cart
sales@molnova.com
RORγt inverse agonist 13
RORγt inverse agonist 13
Catalog No. M28809
RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist (IC50=63.8 nM), with improved drug-like properties.
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 179 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 434 | In Stock |
|
| 100MG | 591 | In Stock |
|
| 200MG | 797 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRORγt inverse agonist 13
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1.Sabry SM, et al. Sensitive spectrofluorimetric and spectrophotometric methods for the determination of thonzylamine hydrochloride in pharmaceutical preparations based on coupling with dimethylbarbituric acid in presence of dicyclohexylcarbodiimide. J Pharm Biomed Anal. 2000 Mar;22(2):257-64.
molnova catalog
related products
-
3-Oxo-5β-cholanoic a...
3-Oxo-5β-cholanoic acid (Dehydrolithocholic acid) is a bile acid metabolite and inhibits the differentiation of TH17 cells by directly binding to the key transcription factor RORγt (Kd: 1.13 μM).
-
SR2211
SR2211 is a specific modulator and an inverse agonist of RORγ(IC50 = 320 nM, Ki = 105 nM).
-
AZD-0284
AZD-0284 is a potent, selective, inverse agonist of the nuclear receptor RORγ for the potential treatment of Plaque psoriasis.
